Skip to content
Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors? episode artwork

Dec 10, 2015 4 min

Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors?

from GRACEcast Hosted by cancerGRACE Meetings

Drs. Ben Solomon, Leora Horn, & Jack West evaluate the evidence and consider whether there are clinically significant differences among the second generation ALK inhibitors that would lead to a reason to prefer one over another for a particular patient.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors?

0:00 4:44

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of GRACEcast?

This episode is 4 minutes long.

When was this GRACEcast episode published?

This episode was published on December 10, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.